Dr. Korthuis is Professor of Medicine at Oregon Health and Science University, Addiction Medicine Section Chief, and Addiction Medicine Fellowship Program Director. He graduated from University of Health Sciences/Chicago Medical School in 1991, primary care internal medicine residency and chief residency at Yale University in 1999, and a health services research fellowship and MPH at University of California Los Angeles in 2002. He began his career caring for patients living with HIV and substance use disorders. His research focuses on integration of pharmacotherapy for substance use disorder treatment in diverse health care settings, including primary care, HIV clinic, and rural settings. He serves as Principal Investigator for several multi-site, NIH-funded clinical trials including: CTN-0067 CHOICES trial of extended-release naltrexone in North American HIV clinics; BRAVO trial of buprenorphine for opioid use disorder in Vietnam HIV clinics; Oregon HOPE study to improve engagement in opioid use disorder treatment in rural Oregon counties; and the PROUD-R2 trial to support retention in people with opioid use disorder in rural Oregon, Ohio, and Kentucky. He is Co-Principal Investigator for the Western States Node of the National Institute of Drug Abuse Clinical Trials Network that conducts clinical trials of opioid, methamphetamine, and cocaine use disorders. Honors include the 2008 Lawrence S. Linn Award for research that improves the lives of people living with HIV and a 2012-2013 Fulbright Scholar award to study integration of HIV and addiction care in Vietnam.

Todd has no disclosures to report.